Evidence map›Paper›PMID 30126457›Full record

ArticleJournal of experimental & clinical cancer research : CR2018

Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.

Valeria Carina, Viviana Costa, Stefania Pagani, Angela De Luca, Lavinia Raimondi, Daniele Bellavia, Stefania Setti, Milena Fini, Gianluca Giavaresi

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Frontiers in pharmacology · 2020
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Valeria CarinaIRCCS Rizzoli Orthopedic Institute, Bologna, Italy. valeria.carina@ior.it.
Viviana CostaIRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Stefania PaganiLaboratory of Preclinical and Surgical Studies, IRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Angela De LucaIRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Lavinia RaimondiIRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Daniele BellaviaIRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Stefania SettiIGEA SpA, Clinical Biophysics, Carpi, Modena, Italy.
Milena FiniLaboratory of Preclinical and Surgical Studies, IRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Gianluca GiavaresiLaboratory of Preclinical and Surgical Studies, IRCCS Rizzoli Orthopedic Institute, Bologna, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Ortopedico Rizzoli · ITIGEA Clinical Biophysics (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBone tissue is one of the main sites for breast metastasis; patients diagnosed with advanced breast cancer mostly develop bone metastasis characterized by severe osteolytic lesions, which heavily influence their life quality. Low Intensity Pulsed Ultrasound (LIPUS) is a form of mechanical energy able to modulate various molecular pathways both in cancer and in health cells. The purpose of the present study was to evaluate for the first time, the ability of LIPUS to modulate osteolytic capability of breast cancer cells.

methodsTwo different approaches were employed: a) Indirect method -conditioned medium obtained by MDA-MB-231 cell line treated or untreated with LIPUS was used to induce osteoclast differentiation of murine macrophage Raw264.7 cell line; and b) Direct method -MDA-MB-231 were co-cultured with Raw264.7 cells and treated or untreated with LIPUS.

resultsLIPUS treatment impaired MDA-MB-231 cell dependentosteoclast differentiation and produced a reduction of osteoclast markers such as Cathepsin K, Matrix Metalloproteinase 9 and Tartrate Resistant Acid Phosphatase, suggesting its role as an effective and safe adjuvant in bone metastasis management.

conclusionLIPUS treatment could be a good and safety therapeutic adjuvant in osteolyitic bone metastasis not only for the induction properties of bone regeneration, but also for the reduction of osteolysis.

Indexed as

Ultrasonic WavesAnimalsBone NeoplasmsBreast NeoplasmsCathepsin KCell DifferentiationCell Line, TumorCoculture TechniquesFemaleMatrix Metalloproteinase 9MiceOsteogenesisOsteolysisRAW 264.7 CellsTartrate-Resistant Acid PhosphataseUltrasonic TherapyCathepsin KMatrix Metalloproteinase 9MMP9 protein, humanTartrate-Resistant Acid PhosphataseBreast cancerLow intensity pulsed ultrasoundOsteoclastsOsteolytic metastasis

Identifiers

PMID30126457
PMCPMC6102871
OpenAlexW2888080003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.